Free Trial

MarketBeat Instant News Alerts

Darden Restaurants logo with Retail/Wholesale background

Oppenheimer Forecasts Strong Price Appreciation for Darden Restaurants (NYSE:DRI) Stock

MarketBeat

Oppenheimer upped their price objective on Darden Restaurants from $230.00 to $250.00 and gave the stock an "outperform" rating in a research note on Wednesday.

NYSE:DRI
Read Oppenheimer Forecasts Strong Price Appreciation for Darden Restaurants (NYSE:DRI) Stock
Zoetis logo with Medical background

Zoetis (NYSE:ZTS) Downgraded to "Hold" Rating by Stifel Nicolaus

MarketBeat

Stifel Nicolaus downgraded Zoetis from a "buy" rating to a "hold" rating and set a $160.00 target price for the company. in a report on Wednesday.

NYSE:ZTS
Read Zoetis (NYSE:ZTS) Downgraded to "Hold" Rating by Stifel Nicolaus
Western Copper & Gold logo with Basic Materials background

Western Copper & Gold (NYSE:WRN) Given New $4.00 Price Target at HC Wainwright

MarketBeat

HC Wainwright lowered their price target on Western Copper & Gold from $4.25 to $4.00 and set a "buy" rating on the stock in a report on Wednesday.

NYSE:WRN
Read Western Copper & Gold (NYSE:WRN) Given New $4.00 Price Target at HC Wainwright
UBS Group logo with Finance background

UBS Group (NYSE:UBS) Lowered to Underweight Rating by Morgan Stanley

MarketBeat

Morgan Stanley downgraded shares of UBS Group from an "equal weight" rating to an "underweight" rating in a research report on Wednesday.

NYSE:UBS
Read UBS Group (NYSE:UBS) Lowered to Underweight Rating by Morgan Stanley
Stoneridge logo with Computer and Technology background

Stoneridge's (SRI) "Outperform" Rating Reiterated at Barrington Research

MarketBeat

Barrington Research reaffirmed an "outperform" rating and set a $16.00 target price on shares of Stoneridge in a research note on Wednesday.

NYSE:SRI
Read Stoneridge's (SRI) "Outperform" Rating Reiterated at Barrington Research
Ralph Lauren logo with Consumer Discretionary background

Ralph Lauren's (RL) Outperform Rating Reiterated at Telsey Advisory Group

MarketBeat

Telsey Advisory Group reaffirmed an "outperform" rating and issued a $315.00 price objective on shares of Ralph Lauren in a research note on Wednesday.

NYSE:RL
Read Ralph Lauren's (RL) Outperform Rating Reiterated at Telsey Advisory Group

Trending News

All MarketBeat Instant News Alerts

REV Group logo with Transportation background

REV Group (NYSE:REVG) Upgraded by Morgan Stanley to Equal Weight Rating

MarketBeat
NYSE:REVG
Read REV Group (NYSE:REVG) Upgraded by Morgan Stanley to Equal Weight Rating
Q2 logo with Computer and Technology background

Q2 (NYSE:QTWO) Now Covered by Analysts at JPMorgan Chase & Co.

MarketBeat
NYSE:QTWO
Read Q2 (NYSE:QTWO) Now Covered by Analysts at JPMorgan Chase & Co.
NIKE logo with Consumer Discretionary background

NIKE (NYSE:NKE) Price Target Lowered to $66.00 at Needham & Company LLC

MarketBeat
NYSE:NKE
Read NIKE (NYSE:NKE) Price Target Lowered to $66.00 at Needham & Company LLC
Loma Negra Compania Industrial Argentina logo with Construction background

Loma Negra Compania Industrial Argentina (NYSE:LOMA) Now Covered by Citigroup

MarketBeat
NYSE:LOMA
Read Loma Negra Compania Industrial Argentina (NYSE:LOMA) Now Covered by Citigroup
Genworth Financial logo with Finance background

Genworth Financial (NYSE:GNW) Upgraded to Outperform at Keefe, Bruyette & Woods

MarketBeat
NYSE:GNW
Read Genworth Financial (NYSE:GNW) Upgraded to Outperform at Keefe, Bruyette & Woods
Smart Share Global logo with Consumer Discretionary background

Smart Share Global (NYSE:EM) Given Neutral Rating at Citigroup

MarketBeat
NYSE:EM
Read Smart Share Global (NYSE:EM) Given Neutral Rating at Citigroup
Chipotle Mexican Grill logo with Retail/Wholesale background

TD Securities Reaffirms Buy Rating for Chipotle Mexican Grill (NYSE:CMG)

MarketBeat
NYSE:CMG
Read TD Securities Reaffirms Buy Rating for Chipotle Mexican Grill (NYSE:CMG)
Verve Therapeutics logo with Medical background

Verve Therapeutics (NASDAQ:VERV) Receives Neutral Rating from HC Wainwright

MarketBeat
NASDAQ:VERV
Read Verve Therapeutics (NASDAQ:VERV) Receives Neutral Rating from HC Wainwright
Verve Therapeutics logo with Medical background

Lifesci Capital Reaffirms "Market Perform" Rating for Verve Therapeutics (NASDAQ:VERV)

MarketBeat
NASDAQ:VERV
Read Lifesci Capital Reaffirms "Market Perform" Rating for Verve Therapeutics (NASDAQ:VERV)
Verve Therapeutics logo with Medical background

Verve Therapeutics' (VERV) "Hold" Rating Reiterated at Jefferies Financial Group

MarketBeat
NASDAQ:VERV
Read Verve Therapeutics' (VERV) "Hold" Rating Reiterated at Jefferies Financial Group
Sarepta Therapeutics logo with Medical background

Sarepta Therapeutics (NASDAQ:SRPT) Downgraded to "Hold" Rating by TD Cowen

MarketBeat
NASDAQ:SRPT
Read Sarepta Therapeutics (NASDAQ:SRPT) Downgraded to "Hold" Rating by TD Cowen
Roivant Sciences logo with Medical background

HC Wainwright Reiterates Buy Rating for Roivant Sciences (NASDAQ:ROIV)

MarketBeat
NASDAQ:ROIV
Read HC Wainwright Reiterates Buy Rating for Roivant Sciences (NASDAQ:ROIV)
Nice logo with Computer and Technology background

Rosenblatt Securities Reaffirms Buy Rating for Nice (NASDAQ:NICE)

MarketBeat
NASDAQ:NICE
Read Rosenblatt Securities Reaffirms Buy Rating for Nice (NASDAQ:NICE)
nCino logo with Computer and Technology background

nCino (NASDAQ:NCNO) Coverage Initiated at JPMorgan Chase & Co.

MarketBeat
NASDAQ:NCNO
Read nCino (NASDAQ:NCNO) Coverage Initiated at JPMorgan Chase & Co.
Marvell Technology logo with Computer and Technology background

Rosenblatt Securities Reaffirms "Buy" Rating for Marvell Technology (NASDAQ:MRVL)

MarketBeat
NASDAQ:MRVL
Read Rosenblatt Securities Reaffirms "Buy" Rating for Marvell Technology (NASDAQ:MRVL)
Marvell Technology logo with Computer and Technology background

Marvell Technology's (MRVL) "Buy" Rating Reaffirmed at Needham & Company LLC

MarketBeat
NASDAQ:MRVL
Read Marvell Technology's (MRVL) "Buy" Rating Reaffirmed at Needham & Company LLC
Marvell Technology logo with Computer and Technology background

Benchmark Reiterates "Buy" Rating for Marvell Technology (NASDAQ:MRVL)

MarketBeat
NASDAQ:MRVL
Read Benchmark Reiterates "Buy" Rating for Marvell Technology (NASDAQ:MRVL)
Innoviz Technologies logo with Auto/Tires/Trucks background

Innoviz Technologies (NASDAQ:INVZ) Given New $2.53 Price Target at Westpark Capital

MarketBeat
NASDAQ:INVZ
Read Innoviz Technologies (NASDAQ:INVZ) Given New $2.53 Price Target at Westpark Capital
Immuneering logo with Medical background

Chardan Capital Reiterates Buy Rating for Immuneering (NASDAQ:IMRX)

MarketBeat
NASDAQ:IMRX
Read Chardan Capital Reiterates Buy Rating for Immuneering (NASDAQ:IMRX)
Immuneering logo with Medical background

Immuneering (NASDAQ:IMRX) Earns "Buy" Rating from Needham & Company LLC

MarketBeat
NASDAQ:IMRX
Read Immuneering (NASDAQ:IMRX) Earns "Buy" Rating from Needham & Company LLC
Eledon Pharmaceuticals logo with Medical background

Eledon Pharmaceuticals' (ELDN) "Buy" Rating Reaffirmed at HC Wainwright

MarketBeat
NASDAQ:ELDN
Read Eledon Pharmaceuticals' (ELDN) "Buy" Rating Reaffirmed at HC Wainwright
Cidara Therapeutics logo with Medical background

Cidara Therapeutics (NASDAQ:CDTX) Receives Buy Rating from HC Wainwright

MarketBeat
NASDAQ:CDTX
Read Cidara Therapeutics (NASDAQ:CDTX) Receives Buy Rating from HC Wainwright
Ardelyx logo with Medical background

HC Wainwright Reiterates "Buy" Rating for Ardelyx (NASDAQ:ARDX)

MarketBeat
NASDAQ:ARDX
Read HC Wainwright Reiterates "Buy" Rating for Ardelyx (NASDAQ:ARDX)
Alkami Technology logo with Computer and Technology background

Alkami Technology (NASDAQ:ALKT) Receives "Overweight" Rating from JPMorgan Chase & Co.

MarketBeat
NASDAQ:ALKT
Read Alkami Technology (NASDAQ:ALKT) Receives "Overweight" Rating from JPMorgan Chase & Co.

Featured Articles and Offers

Sector News